Analyze Diet
Animals : an open access journal from MDPI2021; 11(7); doi: 10.3390/ani11072081

Cardiorespiratory, Sedative and Antinociceptive Effects of a Medetomidine Constant Rate Infusion with Morphine, Ketamine or Both.

Abstract: Standing surgery under sedation reduces anesthetic-related mortality in horses. Medetomidine, alone and combined with morphine in a constant rate infusion (CRI), has been described for standing surgery but their cardiorespiratory, sedative and antinociceptive effects have never been compared. The addition of ketamine could improve analgesia in these procedures with minimal cardiorespiratory consequences. The objectives were to compare the cardiorespiratory effects, quality of sedation, antinociception and ataxia produced by administration of a medetomidine-based CRI with morphine, ketamine or both, in standing horses. A prospective, blind, randomized crossover, experimental design with six healthy adult horses was performed, in which four treatments were administered to all horses with at least two weeks of washout period: medetomidine (M); medetomidine and ketamine (MK); medetomidine and morphine (MMo); and medetomidine, morphine and ketamine (MMoK). Dosages were the same in all treatment groups: medetomidine at 5 µg/kg bwt followed by 5 µg/kg bwt/h, ketamine at 0.4 mg/kg/h and morphine at 50 µg/kg bwt, followed by morphine 30 µg/kg bwt/h. Drug infusions were maintained for 120 min. Cardiorespiratory variables, sedation degree and antinociceptive effects were evaluated during the procedure. All combinations produced similar sedation and antinociceptive effects and no clinically relevant alterations in cardiorespiratory variables occurred. Medetomidine CRI combined with morphine, ketamine or both are suitable and safe protocols for standing sedation in horses and the addition of morphine and/or ketamine did not cause any negative effect but no improving effect on sedation and antinociception was detected.
Publication Date: 2021-07-13 PubMed ID: 34359209PubMed Central: PMC8300393DOI: 10.3390/ani11072081Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The paper studies the cardiorespiratory, sedative, and antinociceptive effects of continuous infusion combinations of medetomidine with morphine, ketamine, or both on standing horses. The study concludes that all these drug combinations are safe, suitable protocols for horse sedation during standing surgeries, and do not significantly alter cardiorespiratory variables or improve sedation and antinociception.

Objective and Design of the Study

  • The primary goal of the research was to compare the impacts of medetomidine, a sedative, combined with morphine or ketamine or both in a constant rate infusion (CRI) on the cardiorespiratory effects, sedation quality, antinociception (pain relief), and ataxia (loss of body movement control) in standing horses. It aimed to find a combination that could enhance pain relief during stand-up surgeries in horses without significantly affecting their cardiorespiratory system.
  • The research employed a prospective, blind, randomized crossover, experimental design on six healthy adult horses. It involved administering four treatments—medetomidine alone, medetomidine with ketamine, medetomidine with morphine, and a combination of medetomidine, morphine and ketamine—to the horses, with a washout period of at least two weeks in between.

Procedure and Measurements

  • The dosages for all treatment groups were the same and the drug infusions lasted for 120 minutes. The researchers then measured the cardiorespiratory variables, sedation degree, and antinociceptive effects during the procedure.
  • The dosage for medetomidine was 5 µg/kg bwt followed by 5 µg/kg bwt/h, for ketamine it was 0.4 mg/kg/h, and for morphine it was 50 µg/kg bwt, followed by morphine 30 µg/kg bwt/h.

Findings

  • All of the drug combinations resulted in similar sedation and antinociceptive effects, and none caused clinically relevant changes in the cardiorespiratory variables.
  • The medetomidine CRI, in combination with morphine, ketamine, or both, are suitable and safe protocols for standing sedation in horses.
  • However, adding morphine and/or ketamine to the medetomidine CRI did not have any negative effects nor did it improve the sedation and antinociceptive effects.

Cite This Article

APA
Troya-Portillo L, López-Sanromán J, Villalba-Orero M, Santiago-Llorente I. (2021). Cardiorespiratory, Sedative and Antinociceptive Effects of a Medetomidine Constant Rate Infusion with Morphine, Ketamine or Both. Animals (Basel), 11(7). https://doi.org/10.3390/ani11072081

Publication

ISSN: 2076-2615
NlmUniqueID: 101635614
Country: Switzerland
Language: English
Volume: 11
Issue: 7

Researcher Affiliations

Troya-Portillo, Lucas
  • Departamento de Medicina y Cirugía Animal, Universidad Complutense de Madrid, 28040 Madrid, Spain.
López-Sanromán, Javier
  • Departamento de Medicina y Cirugía Animal, Universidad Complutense de Madrid, 28040 Madrid, Spain.
  • Hospital Clínico Veterinario Complutense, Universidad Complutense de Madrid, 28040 Madrid, Spain.
Villalba-Orero, María
  • Departamento de Medicina y Cirugía Animal, Universidad Complutense de Madrid, 28040 Madrid, Spain.
Santiago-Llorente, Isabel
  • Hospital Clínico Veterinario Complutense, Universidad Complutense de Madrid, 28040 Madrid, Spain.

Grant Funding

  • N/A / Fundación General de la Universidad Complutense de Madrid

Conflict of Interest Statement

The authors declare no conflict of interest.

References

This article includes 69 references
  1. Brodbelt DC, Blissitt KJ, Hammond RA, Neath PJ, Young LE, Pfeiffer DU, Wood JLN. The risk of death: The Confidential Enquiry into Perioperative Small Animal Fatalities.. Vet. Anaesth. Analg. 2008;35:365–373.
  2. Li G, Warner M, Lang BH, Huang L, Sun LS. Epidemiology of Anesthesia-related Mortality in the United States, 1999–2005.. Anesthesiology 2009;110:759–765.
  3. Johnston GM. Findings from the CEPEF epidemiological studies into equine perioperative complications.. Equine Vet. Educ. 2005;15:64–68.
  4. Bidwell LA, Bramlage LR, Rood WA. Equine perioperative fatalities associated with general anaesthesia at a private practice—A retrospective case series.. Vet. Anaesth. Analg. 2007;34:23–30.
  5. Senior MK. Morbidity, mortality, and risk of general anesthesia in horses.. Vet. Clin. N. Am. Equine Pract. 2013;29:1–18.
    doi: 10.1016/j.cveq.2012.11.007pubmed: 23498043google scholar: lookup
  6. Johnston GM, Eastment JK, Wood JL, Taylor PM. The confidential equiry into perioperative equine fatalities (CEPEF): Mortality results of Phases 1 and 2.. Vet. Anaesth. Analg. 2000;29:159–170.
  7. Doherty T, Valverde A. Manual of Equine Anesthesia and Analgesia.. Blackwell Publishing Ltd; Oxford, UK: 2006.
  8. Michou J, Leece E. Sedation and analgesia in the standing horse 1. Drugs used for sedation and systemic analgesia.. In Pract. 2012;34:524–531.
    doi: 10.1136/inp.e6423google scholar: lookup
  9. Muir WW, Hubbell JAE. Equine Anesthesia.. Elsevier; Amsterdam, The Netherlands: 2009.
  10. Bettschart-Wolfensberger R, Clarke KW, Vainio O, Aliabadi FS, Demuth D. Pharmacokinetics of medetomidine in ponies and elaboration of a medetomidine infusion regime which provides a constant level of sedation.. Res. Vet. Sci. 1999;67:41–46.
    doi: 10.1053/rvsc.1998.0274pubmed: 10425239google scholar: lookup
  11. Bueno AC, Cornick-Seahorn J, Seahorn TL, Hosgood G, Moore RM. Cardiopulmonary and sedative effects of intravenous administration of low doses of medetomidine and xylazine to adult horses.. Am. J. Vet. Res. 1999;60:1371–1376.
    pubmed: 10566811
  12. Yamashita K, Tsubakishita S, Futaoka S, Ueda I, Hamaguchi H, Seno T, Katoh S, Izumisawa Y, Kotani T, William WM. Cardiovascular Effects of Medetomidine, Detomidine and Xylazine in Horses.. J. Vet. Med. Sci. 2000;62:1025–1032.
    doi: 10.1292/jvms.62.1025pubmed: 11073071google scholar: lookup
  13. Muir WW, Skarda RT, Sheehan WC. Hemodynamic and respiratory effects of xylazine-morphine sulfate in horses.. Am. J. Vet. Res. 1979;40:1417–1420.
    pubmed: 525863
  14. Kalpravidh M, Lumb WV, Wright M, Heath RB. Effects of butorphanol, flunixin, levorphanol, morphine, and xylazine in ponies.. Am. J. Vet. Res. 1984;45:217–223.
    pubmed: 6711945
  15. Boscan P, Van Hoogmoed LM, Farver TB, Snyder JR. Evaluation of the effects of the opioid agonist morphine on gastrointestinal tract function in horses.. Am. J. Vet. Res. 2006;67:992–997.
    doi: 10.2460/ajvr.67.6.992pubmed: 16740092google scholar: lookup
  16. Muir WW, Skarda RT, Sheehan WC. Cardiopulmonary effects of narcotic agonists and a partial agonist in horses.. Am. J. Vet. Res. 1978;39:1632–1635.
    pubmed: 717878
  17. Roberts MC, Argenzio A. Effects of amitraz, several opiate derivatives and anticholinergic agents on intestinal transit in ponies.. Equine Vet. J. 1986;18:256–260.
  18. Clark L, Clutton RE, Blissitt KJ, Chase-Topping ME. Effects of peri-operative morphine administration during halothane anaesthesia in horses.. Vet. Anaesth. Analg. 2005;32:10–15.
  19. Solano AM, Valverde A, Desrochers A, Nykamp S, Boure LP. Behavioural and cardiorespiratory effects of a constant rate infusion of medetomidine and morphine for sedation during standing laparoscopy in horses.. Equine Vet. J. 2009;41:153–159.
    doi: 10.2746/042516408X342984pubmed: 19418744google scholar: lookup
  20. Benredouane K, Ringer SK, Fourel I, Lepage OM, Portier KG, Bettschart-Wolfensberger R. Short communications: Comparison of xylazine-butorphanol and xylazine-morphine-ketamine infusions in horses undergoing a standing surgery.. Vet. Rec. 2011;169:364.
    doi: 10.1136/vr.d5333pubmed: 21896566google scholar: lookup
  21. Lankveld DPK, Bull S, Van Dijk P, Fink-Gremmels J, Hellebrekers LJ. Ketamine inhibits LPS-induced tumour necrosis factor-alpha and interleukin-6 in an equine macrophage cell line.. Vet. Res. 2005;36:257–262.
    doi: 10.1051/vetres:2004061pubmed: 15720977google scholar: lookup
  22. Lankveld DPK, Driessen B, Soma LR, Moate PJ, Rudy J, Uboh CE, Dijk PVAN, Hellebrekers LJ, Rudy J, Dijk V. Pharmacodynamic effects and pharmacokinetic profile of a long-term continuous rate infusion of racemic ketamine in healthy conscious horses.. J. Vet. Pharmacol. Ther. 2006;29:477–488.
  23. Petrenko AB, Yamakura T, Baba H, Shimoji K. The role of N-methyl-D-aspartate (NMDA) receptors in pain: A review.. Anesth. Analg. 2003;97:1108–1116.
  24. Müller TM, Hopster K, Bienert-Zeit A, Rohn K, Kästner SBR. Effect of butorphanol, midazolam or ketamine on romifidine based sedation in horses during standing cheek tooth removal.. BMC Vet. Res. 2017;13:381.
    doi: 10.1186/s12917-017-1299-6pmc: PMC5719754pubmed: 29212478google scholar: lookup
  25. Blissitt KJ, Young LE, Jones RS, Darke PGG, Utting J. Measurement of cardiac output in standing horses by Doppler echocardiography and thermodilution.. Equine Vet. J. 1997;29:18–25.
  26. Ringer SK, Portier KG, Fourel I, Bettschart-Wolfensberger R. Development of a romifidine constant rate infusion with or without butorphanol for standing sedation of horses.. Vet. Anaesth. Analg. 2012;39:12–20.
  27. Ringer SK, Portier KG, Fourel I, Bettschart-Wolfensberger R. Development of a xylazine constant rate infusion with or without butorphanol for standing sedation of horses.. Vet. Anaesth. Analg. 2012;39:1–11.
  28. Chambers JP, Livingston A, Waterman AE. A device for testing nociceptive thresholds in horses.. J. Assoc. Vet. Anaesth. Gt. Britain Irel. 1990;17:42–44.
  29. Chambers JP, Waterman AE, Livingston A. Further development of equipment to measure nociceptive thresholds in large animals.. Vet. Anaesth. Analg. 1994;21:66–72.
  30. Haussler KK, Erb HN. Mechanical nociceptive thresholds in the axial skeleton of horses.. Equine Vet. J. 2006;38:70–75.
    doi: 10.2746/042516406775374315pubmed: 16411590google scholar: lookup
  31. Haussler KK. Pressure Algometry for the Detection of Mechanical Nociceptive Thresholds in Horses.. Animals 2020;10:2195.
    doi: 10.3390/ani10122195pmc: PMC7760268pubmed: 33255216google scholar: lookup
  32. Merritt AM, Burrow JA, Hartless CS. Effect of xylazine, detomidine, and a combination of xylazine and butorphanol on equine duodenal motility.. Am. J. Vet. Res. 1998;59:619–623.
    pubmed: 9582967
  33. Freeman SL, England GC. Effect of romifidine on gastrointestinal motility, assessed by transrectal ultrasonography.. Equine Vet. J. 2001;33:570–576.
    doi: 10.2746/042516401776563436pubmed: 11720028google scholar: lookup
  34. Daunt DA, Steffey EP. Alpha-2 adrenergic agonists as analgesics in horses.. Vet. Clin. North Am. Equine Pract. 2002;18:39–46.
    doi: 10.1016/S0749-0739(02)00004-4pubmed: 12064181google scholar: lookup
  35. Sinclair MD. A review of the physiological effects of alpha2-agonists related to the clinical use of medetomidine in small animal practice.. Can. Vet. J. 2003;44:885–897.
    pmc: PMC385445pubmed: 14664351
  36. Tapio H, Raekallio MR, Mykkänen A, Männikkö S, Scheinin M, Bennett RC, Vainio O. Effects of vatinoxan on cardiorespiratory function and gastrointestinal motility during constant-rate medetomidine infusion in standing horses.. Equine Vet. J. 2019;51:646–652.
    doi: 10.1111/evj.13085pmc: PMC6767159pubmed: 30793362google scholar: lookup
  37. Rousseau-Blass F, Pigé C, Pang DS. Agreement between invasive and oscillometric arterial blood pressure measurements using the LifeWindow multiparameter monitor and two cuff sizes in anesthetized adult horses.. Vet. Anaesth. Analg. 2020;47:315–322.
    doi: 10.1016/j.vaa.2020.01.001pubmed: 32199796google scholar: lookup
  38. Parry BW, Gay CC, McCarthy MA. Influence of head height on arterial blood pressure in standing horses.. Am. J. Vet. Res. 1980;41:1626–1631.
    pubmed: 7224287
  39. Mcconachie E, Barton MH, Rapoport G, Giguère S. Doppler and volumetric echocardiographic methods for cardiac output measurement in standing adult horses.. J. Vet. Intern. Med. 2013;27:324–330.
    doi: 10.1111/jvim.12034pubmed: 23323806google scholar: lookup
  40. Zhang Y, Wang Y, Shi J, Hua Z, Xu J. Cardiac output measurements via echocardiography versus thermodilution: A systematic review and meta-analysis.. PLoS ONE 2019;14:e0222105.
  41. Figueiredo JP, Muir WW, Sams R. Cardiorespiratory, gastrointestinal, and analgesic effects of morphine sulfate in conscious healthy horses.. Am. J. Vet. Res. 2012;73:799–808.
    doi: 10.2460/ajvr.73.6.799pubmed: 22620693google scholar: lookup
  42. Gozalo-Marcilla M, Luna SP, Crosignani N, Filho JNP, Possebon FS, Pelligand L, Taylor PM. Sedative and antinociceptive effects of different combinations of detomidine and methadone in standing horses.. Vet. Anaesth. Analg. 2017;44:1116–1127.
    doi: 10.1016/j.vaa.2017.03.009pubmed: 29050998google scholar: lookup
  43. Marly C, Bettschart-Wolfensberger R, Nussbaumer P, Moine S, Ringer SK. Evaluation of a romifidine constant rate infusion protocol with or without butorphanol for dentistry and ophthalmologic procedures in standing horses.. Vet. Anaesth. Analg. 2014;41:491–497.
    doi: 10.1111/vaa.12174pubmed: 24835127google scholar: lookup
  44. Gozalo-Marcilla M, Oliveira AR, Fonseca MW, Possebon FS, Pelligand L, Taylor PM, Luna SPL. Sedative and antinociceptive effects of different detomidine constant rate infusions, with or without methadone in standing horses.. Equine Vet. J. 2019;51:530–536.
    doi: 10.1111/evj.13054pubmed: 30485499google scholar: lookup
  45. Schauvliege S, Cuypers C, Michielsen A, Gasthuys F, Gozalo-Marcilla M. How to score sedation and adjust the administration rate of sedatives in horses: A literature review and introduction of the Ghent Sedation Algorithm.. Vet. Anaesth. Analg. 2019;46:4–13.
    doi: 10.1016/j.vaa.2018.08.005pubmed: 30528671google scholar: lookup
  46. De Oliveira AR, Gozalo-Marcilla M, Ringer SK, Schauvliege S, Fonseca MW, Trindade PHE, Puoli Filho JNP, Luna SPL. Development, Validation, and Reliability of a Sedation Scale in Horses (EquiSed). Front. Vet. Sci. 2021;8.
    doi: 10.3389/fvets.2021.611729pmc: PMC7921322pubmed: 33665216google scholar: lookup
  47. Lizarraga I, Beths T. A comparative study of xylazine-induced mechanical hypoalgesia in donkeys and horses.. Vet. Anaesth. Analg. 2012;39:533–538.
  48. Lizarraga I, Janovyak E. Comparison of the mechanical hypoalgesic effects of five α2-adrenoceptor agonists in donkeys.. Vet. Rec. 2013;173:294.
    doi: 10.1136/vr.101684pubmed: 23878192google scholar: lookup
  49. Lizarraga I, Castillo-Alcala F, Robinson LS. Comparison of sedation and mechanical antinociception induced by intravenous administration of acepromazine and four dose rates of dexmedetomidine in donkeys.. Vet. Anaesth. Analg. 2017;44:509–517.
    doi: 10.1016/j.vaa.2016.08.003pubmed: 28291587google scholar: lookup
  50. Sanchez LC, Elfenbein JR, Robertson SA. Effect of acepromazine, butorphanol, or N-butylscopolammonium bromide on visceral and somatic nociception and duodenal motility in conscious horses.. Am. J. Vet. Res. 2008;69:579–585.
    doi: 10.2460/ajvr.69.5.579pubmed: 18447787google scholar: lookup
  51. Carregaro AB, Luna SPL, Mataqueiro MI, Queiroz-Neto A de. Effects of buprenorphine on nociception and spontaneous locomotor activity in horses.. Am. J. Vet. Res. 2007;68:246–250.
    doi: 10.2460/ajvr.68.3.246pubmed: 17331012google scholar: lookup
  52. Spadavecchia C, Arendt-Nielsen L, Spadavecchia L, Mosing M, Auer U, Van Den Hoven R. Effects of butorphanol on the withdrawal reflex using threshold, suprathreshold and repeated subthreshold electrical stimuli in conscious horses.. Vet. Anaesth. Analg. 2007;34:48–58.
  53. Dönselmann Im Sande P, Hopster K, Kästner S. Effects of morphine, butorphanol and levomethadone in different doses on thermal nociceptive thresholds in horses.. Tierarztl. Prax. Ausg. G Grosstiere Nutztiere. 2017;45:98–106.
    doi: 10.15653/TPG-160655pubmed: 28075433google scholar: lookup
  54. McGowan KT, Elfenbein JR, Robertson SA, Sanchez LC. Effect of butorphanol on thermal nociceptive threshold in healthy pony foals.. Equine Vet. J. 2013;45:503–506.
  55. Schatzmann U, Armbruster S, Stucki F, Busato A, Kohler I. Analgesic Effect of Butorphanol and Levomethadone in Detomidine Sedated Horses.. J. Vet. Med. Ser. A. 2001;48:337–342.
  56. Bennett RC, Steffey EP. Use of opioids for pain and anesthetic management in horses.. Vet. Clin. North Am. Equine Pract. 2002;18:47–60.
    doi: 10.1016/S0749-0739(02)00011-1pubmed: 12064182google scholar: lookup
  57. Echelmeyer J, Taylor PM, Hopster K, Rohn K, Delarocque J, Kästner SBR. Effect of fentanyl on thermal and mechanical nociceptive thresholds in horses and estimation of anti-nociceptive plasma concentration.. Vet. J. 2019;249:82–88.
    doi: 10.1016/j.tvjl.2019.05.012pubmed: 31239171google scholar: lookup
  58. Crabtree NE, Mochal-King CA, Sloan PB, Eddy AL, Wills RW, Meredith AN, Fontenot RL. Synovial butorphanol concentrations and mechanical nociceptive thresholds after intravenous regional limb perfusion in standing sedated horses.. Vet. Surg. 2019;48:1473–1482.
    doi: 10.1111/vsu.13309pubmed: 31513300google scholar: lookup
  59. Villalba M, Santiago I, De Segura IAG. Effects of constant rate infusion of lidocaine and ketamine, with or without morphine, on isoflurane MAC in horses.. Equine Vet. J. 2011;43:721–726.
  60. Clutton RE. Opioid Analgesia in Horses.. Vet. Clin. N. Am. Equine Pract. 2010;26:493–514.
    doi: 10.1016/j.cveq.2010.07.002pubmed: 21056296google scholar: lookup
  61. Knobloch M, Portier CJ, Levionnois OL, Theurillat R, Thormann W. Antinociceptive effects, metabolism and disposition of ketamine in ponies under target-controlled drug infusion.. Toxicol. Appl. Pharmacol. 2006;216:373–386.
    doi: 10.1016/j.taap.2006.06.011pmc: PMC2039908pubmed: 16919695google scholar: lookup
  62. López-Sanromán FJ, Cruz JM, Santos M, Mazzini RA, Tabanera A, Tendillo FJ. Evaluation of the local analgesic effect of ketamine in the palmar digital nerve block at the base of the proximal sesamoid (abaxial sesamoid block) in horses.. Am. J. Vet. Res. 2003;64:475–478.
    doi: 10.2460/ajvr.2003.64.475pubmed: 12693539google scholar: lookup
  63. Svensson P, Baad-Hansen L, Pigg M, List T, Eliav E, Ettlin D, Michelotti A, Tsukiyama Y, Matsuka Y, Jääskeläinen SK. Guidelines and recommendations for assessment of somatosensory function in oro-facial pain conditions—A taskforce report.. J. Oral Rehabil. 2011;38:366–394.
  64. Lopes C, Luna SPL, Rosa AC, Quarterone C, Crosignani N, Taylor PM, Pantoja JC, Puoli JNP. Antinociceptive effects of methadone combined with detomidine or acepromazine in horses.. Equine Vet. J. 2016;48:613–618.
    doi: 10.1111/evj.12483pubmed: 26174473google scholar: lookup
  65. Luna SPL, Lopes C, Rosa AC, Oliveira FA, Crosignani N, Taylor PM, Pantoja JC. Validation of mechanical, electrical and thermal nociceptive stimulation methods in horses.. Equine Vet. J. 2015;47:609–614.
    doi: 10.1111/evj.12332pubmed: 25130475google scholar: lookup
  66. Clarke KW, Paton BS. Combined use of detomidine with opiates in the horse.. Equine Vet. J. 1988;20:331–334.
  67. Ringer SK, Portier K, Torgerson PR, Castagno R, Bettschart-Wolfensberger R. The effects of a loading dose followed by constant rate infusion of xylazine compared with romifidine on sedation, ataxia and response to stimuli in horses.. Vet. Anaesth. Analg. 2013;40:157–165.
  68. Love EJ, Murrell J, Whay HR. Thermal and mechanical nociceptive threshold testing in horses: A review.. Vet. Anaesth. Analg. 2011;38:3–14.
  69. Nielsen CS, Staud R, Price DD. Individual differences in pain sensitivity: Measurement, causation, and consequences.. J. Pain. 2009;10:231–237.
    doi: 10.1016/j.jpain.2008.09.010pubmed: 19185545google scholar: lookup